NCT03690284 is a NA clinical trial of Conventional Double Lumen Tube in Double Lumen Endotracheal Tube, sponsored by University of Texas Southwestern Medical Center.

Who is sponsoring NCT03690284?

NCT03690284 is sponsored by University of Texas Southwestern Medical Center.

What drugs are being tested in NCT03690284?

Interventions in NCT03690284: Conventional Double Lumen Tube, VivaSight Double Lumen Tube.

What condition does NCT03690284 study?

NCT03690284 studies Double Lumen Endotracheal Tube, Single Lung Ventilation.

Is NCT03690284 still recruiting?

NCT03690284 is currently completed. Last updated 14 January 2022.

Are results published for NCT03690284?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-01-14 · How we verify

NCT03690284

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VivaSight Double Lumen Tube for Single Lung Ventilation

Completed NA Results posted Last updated 14 January 2022

What this trial tests

NA trial testing Conventional Double Lumen Tube in Double Lumen Endotracheal Tube in 50 participants. Completed in 31 December 2020.

Timeline

19 June 2019

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	University of Texas Southwestern Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	50
Start date	19 June 2019
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

Conventional Double Lumen Tube
VivaSight Double Lumen Tube

Conditions studied

Double Lumen Endotracheal Tube — all drugs for Double Lumen Endotracheal Tube →
Single Lung Ventilation — all drugs for Single Lung Ventilation →

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 18 to 90, any sex, with Double Lumen Endotracheal Tube or Single Lung Ventilation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Participants Requiring Flexible Fiberoptic Bronchoscopy Primary · Intraoperative, within the time the double lumen was in the trachea

The number of participants requiring flexible fiberoptic bronchoscopy during double-lumen tube intubation for a single lung ventilation.

Group	Value	95% CI
Conventional Double Lumen Tube	25
VivaSight Double Lumen Tube	7

The Intubation Time Secondary · Intraoperative, time to successfully intubate patient.

The time required to place double lumen endotracheal tube for a single lung intubation

Group	Value	95% CI
Conventional Double Lumen Tube	156	103 – 174
VivaSight Double Lumen Tube	54	45 – 81

Number of Participants With Malposition Secondary · Intraoperative, within the time the double lumen was in the trachea

The number of participants with malposition of double lumen tube for a single lung intubation

Group	Value	95% CI
Conventional Double Lumen Tube	12
VivaSight Double Lumen Tube	4

Sponsor's own description

This prospective, randomized, comparative study is intended to enroll a total of 50 patients undergoing thoracic surgery that necessitates single lung ventilation. The efficacy and performance of the VivaSight DLT will be compared to the conventional double lumen tube. Use of fiberoptic bronchoscopy for initial tube positioning and subsequently during the case will be recorded. The attending thoracic surgeon will judge the quality of lung deflation. The occurrence of any malposition and subsequent maneuvers will be recorded. A standardized anesthetic protocol that is usual and customary for the type of operation the patient is having will be provided to the anesthesia teams of enrolled subjects. The remainder of the anesthetic care of the subject will not deviate from the standard of care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03690284 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 14 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03690284.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing